MLTX stock news
This page provides real-time market news, earnings updates, and company announcements related to MoonLake Immunotherapeutics (MLTX).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-03-01 19:37 EST
Hyperliquid News Today: The Meme Coin Surge in Crypto Sparks Debate Between Hype and Real Worth
Bitget-RWA2025-11-04 02:40:04
Digital assets are expanding rapidly, fueled by advancements in AI and blockchain technology, even as meme coin speculation continues.
Bitget-RWA2025-11-05 01:38:05
Ethereum News Update: As Solana Slows Down, Investors Turn Attention to XRP and Ethereum
Bitget-RWA2025-11-14 21:46:10
LUNA rises by 2.66% despite ongoing legal uncertainties and unstable market conditions
Bitget-RWA2025-11-15 05:21:59
Bitcoin’s Sharp Decline: Is It a Healthy Adjustment or an Ominous Sign?
Bitget-RWA2025-11-25 16:20:13
Law Firms Take Action Against Corporations Amid Rising Investor Lawsuits
Bitget-RWA2025-11-27 09:00:28
Stocks Rise on Hopes for Increased Chip Demand
101 finance2026-01-16 00:42:32
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Finviz2026-02-22 16:03:14
Biotechnology company MoonLake Immunotherapeutics announced that its innovative drug Sonelokimab achieved positive topline results in a Phase II clinical trial for axial spondyloarthritis.
老虎证券2026-02-22 16:06:48
Bitcoin’s Sharp Decline: Is It a Healthy Adjustment or an Ominous Sign?
Bitget-RWA2025-11-25 16:20:13
Law Firms Take Action Against Corporations Amid Rising Investor Lawsuits
Bitget-RWA2025-11-27 09:00:28
Stocks Rise on Hopes for Increased Chip Demand
101 finance2026-01-16 00:42:32
MoonLake Announces Positive Topline Results from its Phase 2 Clinical Trial of Sonelokimab in Axial Spondyloarthritis and Reports 2025 Financial Results
Finviz2026-02-22 16:03:14
Biotechnology company MoonLake Immunotherapeutics announced that its innovative drug Sonelokimab achieved positive topline results in a Phase II clinical trial for axial spondyloarthritis.
老虎证券2026-02-22 16:06:48
MLTX stock chart
MLTX stock detailsMLTX stock price change
On the last trading day, MLTX stock closed at 17.51 USD, with a price change of -0.96% for the day.
Trade stock perpsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more